title: Endovascular stenting of thoracic aortic aneurysm.
abstract: In 2005, the findings of the multicenter Gore Tag study led to United States Food and Drug Administration approval for endovascular repair of thoracic aortic aneurysms (TEVAR). TEVAR provides a therapeutic option for patients who have thoracic aortic aneurysm and for the treatment of type B aortic dissection with malperfusion. Spinal cord ischemia and stroke are recognized neurologic complications of TEVAR. Identification of high-risk patients combined with targeted anesthetic and perioperative management may decrease the risk of neurologic complications after TEVAR.
authors.affiliation: Department of Anesthesiology and Critical Care, Dulles 6, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. gutschej@uphs.upenn.edu
authors.forename: Jacob T
authors.initials: JT
authors.lastname: Gutsche
authors.forename: Wilson
authors.initials: W
authors.lastname: Szeto
authors.forename: Albert T
authors.initials: AT
authors.lastname: Cheung